Hepcidin is a key iron-regulatory hormone produced by the liver. Inappropriately low hepcidin levels cause iron overload, while increased hepcidin expression plays an important role in the anaemia of inflammation (AI) by restricting intestinal iron absorption and macrophage iron release. Its expression is modulated in response to body iron stores, hypoxia, inflammatory and infectious stimuli, involving at least in part cytokines secreted by macrophages. In this study we established and characterized IL-6-mediated hepcidin activation in the human liver cell line Huh7. We show that the proximal 165bp of the hepcidin promoter are critical for hepcidin activation in response to exogenously administered or to conditioned medium from the monocyte/macrophage cell line THP-1. Importantly, we show that hepcidin activation by these stimuli requires a STAT-3 binding motif located at position -64/-72 of the promoter. The same STAT binding site is also required for high basal level hepcidin mRNA expression under control culture conditions, and siRNA-mediated RNA knock-down of STAT-3 strongly reduces hepcidin mRNA expression. These results identify a missing link in the acute phase activation of hepcidin and establish STAT-3 as a key effector of baseline hepcidin expression and during inflammatory conditions.
INTRODUCTION
The iron-regulatory hormone and hepatic acute phase protein hepcidin is strongly implicated in the anaemia of inflammation (AI), a common clinical disorder that affects patients with acute and chronic infections, trauma, inflammatory disorders and malignancies. The disease is characterized by hypoferremia, low serum iron-binding capacity and normal to elevated ferritin levels 1 . Several cytokines that participate in the pathogenesis of AI also modulate iron metabolism. For example, IL-1
and TNF-α induce hypoferremia in mice, and IL-6 increases hepatic ferritin synthesis and transferrin uptake in rats [2] [3] [4] [5] . Importantly, hypoferremia is induced within few hours after injection of hepcidin into mice 6 . Hepcidin binds to the iron export protein ferroportin (also known as SLC11A3, IREG1
and MTP) and triggers its degradation to decrease iron egress from duodenal enterocytes, macrophages and hepatocytes, thus contributing to the hypoferremia that hallmarks AI 7 . Hepcidin may hence be considered to be a principal iron regulatory hormone, a key mediator of AI, and a bridge between innate immunity and iron metabolism.
IL-6 induces hepcidin expression both in cell culture and in vivo 8, 9 . Conditioned medium from LPStreated macrophages activates hepcidin mRNA expression in hepatocytes, a response that can be blocked by anti-IL-6 antibodies 8, 10 . However, additional factors seem to regulate hepcidin expression, because mice with a targeted disruption of the IL-6 gene (IL-6 -/-) still activate hepcidin expression in response to endotoxin injection 11 . Interestingly, the treatment of primary mouse hepatocytes with IL-1α and IL-1β strongly increases hepcidin mRNA expression 10 . Moreover, a previous report suggests that mice lacking the protein HFE fail to mount an appropriate hepcidin response following LPS injection in spite of a normal increase in IL-6 expression 12 , although other investigators have reached different conclusions using different experimental systems 11 . Taken together, these results reflect the complexity of hepcidin regulation by inflammatory stimuli.
HFE, TfR2 and hemojuvelin (HJ), three genes mutated in a group of frequent iron overload disorders, the hereditary hemochromatosis (HH), control appropriate hepcidin expression [13] [14] [15] [16] [17] [18] [19] [20] . . Further work supports a role for the TGF-beta pathway and SMAD4 in the transcriptional activation of hepcidin in response to iron overload or IL-6 22 . The hepcidin response to TGF-β was abrogated in SMAD4-deficient hepatocytes 22 , and mice with a liver-specific SMAD4 deficiency develop iron overload 22 . Hepcidin expression is further affected by the CCAAT/enhancer- Little information is presently available about promoter elements and transcription factors that control hepcidin expression. To address this issue, we established a cell-based assay system to investigate the cis-acting elements and trans-acting factors for basal hepcidin expression and in response to inflammatory stimuli. We show that a STAT-binding motif at position -64/-72 of the hepcidin promoter and STAT-3 are critical for the control of baseline hepcidin mRNA expression and under inflammatory conditions.
MATERIAL AND METHODS

Cell culture
Human hepatocarcinoma Huh7 and monocyte/macrophage THP-1 cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM; high glucose; Invitrogen). Medium was supplemented with 10% heat-inactivated low endotoxin fetal bovine serum (FBS, Invitrogen) and 100 U/ml penicillin, and 100 µg/ml streptomycin. All cultures were maintained at 37°C under 5% CO 2 .
Cell-free conditioned medium (CM) from THP-1 cells growing at an initial cell confluence of 70% was collected 12h, 24h, 48h and 72h after plating of the cells and used undiluted to treat Huh7 cells.
Human recombinant IL-6 (Roche) was used at final concentrations of 1ng/ml.
RNA isolation
Total RNA was isolated using the Qiagen RNAeasy kit according to the manufacturer's instruction (Qiagen). The concentration and purity of the RNA was determined by OD260/280 reading. The quality of the RNA was assessed by gel electrophoresis and ethidium bromide staining. The mRNA/cDNA abundance of each gene was calculated relative to the expression of a housekeeping gene, GAPDH (glyceraldehyde-3-phosphate-dehydrogenase).
Reverse transcription and quantitative Real-Time PCR analysis
Promoter analysis
-942-bp and -165-bp nucleotide fragments of the 5´-flanking genomic region plus the 5´UTR of the human hepcidin gene were obtained from human genomic DNA by PCR amplifications using the following forward primers: 5´-GGCTCGAGGTACTCATCGGACTGTAGAT-3´ and 5´- 
Cell transfection and Luciferase Assay
Huh7 cells were seeded at 30% confluency in 35-mm-diameter dishes and grown over night. 500ng of 
siRNA-mediated Knock-down of C/EBPα and STAT-3
Huh7 cells were seeded at 30% confluency in DMEM supplemented with 10% low endotoxin FBS without antibiotics. After 24h, cells were transfected using Oligofectamine Reagent (Invitrogen) and 100nM of siRNA directed against C/EBPα (Dharmacon) or STAT-3 (Dharmacon). After further 24h a second round of transfection was performed and the cells were harvested 24 later. As a control siRNA directed against Luciferase (Dharmacon) was transfected. The efficiency of the knock-down was analysed at the mRNA level by quantitative real-time PCR.
Statistics
Results were expressed as mean ± S.D. Student´s t test was used for estimation of statistical significance. 
RESULTS
IL6-dependent hepcidin activation is mediated by a STAT
STAT-3 mediates hepcidin expression
A previous report identified a putative C/EBPα binding site at position -231/-222 of the hepcidin promoter and suggested that C/EBPα is required for high level hepcidin mRNA expression both in Huh7 cells and mice 23 . Here we show that a truncation of the hepcidin promoter to -385-bp does not affect the luciferase read out in unstimulated control Huh7 cells. A further truncation to -165-bp, however, reduces luciferase activity more than 3-fold after transfection ( Figure 3A) . Because the C/EBPα binding site is located within this deleted promoter region, we assessed the effect of siRNAmediated knockdown of C/EBPα on endogenous hepcidin expression in Huh7 cells ( Figure 3B ). As expected, the knock-down of C/EBPα decreased hepcidin mRNA expression, confirming previous reports ( Figure 3B ).
To investigate whether the STAT binding motif at position -64/-72, which mediates the IL-6 activation of the hepcidin promoter (Figure 2A ), is also required to maintain high level luciferase expression in untreated Huh7 cells, we analyzed the -942 ∆ STAT construct. Interestingly, we observed a 9,3 fold reduction of luciferase activity compared to the 942-bp construct, suggesting a role for this putative STAT binding site in maintaining high level hepcidin mRNA expression ( Figure 4A ).
To determine whether the STAT-3 transcription factor that is predicted to interact with this binding motif controls hepcidin mRNA expression, we performed siRNA-mediated knock-down of STAT-3.
A knock-down of STAT-3 mRNA levels to 90% caused a 9-fold decrease in endogenous hepcidin 
shows that the hepcidin response (approx. 10-fold after addition of CM(48h) for 24h) is at least partially mediated via the hepcidin promoter. This induction is retained in the absence of the AP-1 binding site in the -385bp construct (data not shown), indicating that the AP-1 site does not contribute to this activation. However, the deletion of the putative STAT binding site in the -165bp hepcidin promoter construct completely abrogates the responsiveness of the promoter construct to the CM from macrophages, demonstrating that the STAT binding motif is critically important for the transcriptional activation of the hepcidin promoter both in response to IL-6 and CM.
For
DISCUSSION
Hepcidin is a key regulatory hormone that plays a central role in frequent clinical disorders like hereditary hemochromatosis (HH) and the anaemia of inflammation (AI). Hepcidin expression
increases in response to iron overload and inflammatory stimuli to reduce duodenal iron absorption and to increase iron retention in the reticuloendothelial system (RES). In the setting of AI, these responses result in hypoferremia, a common hallmark of this disease 26 . On the contrary, inappropriately low hepcidin expression in the iron overload disorder HH causes increased iron absorption and iron accumulation in the liver and other parenchymal organs.
To understand the control of hepcidin expression, we investigated the regulatory, cis-acting elements A previous report suggested that C/EBPα also controls hepcidin transcription 23 . In Huh7 cells, the deletion of the putative C/EBPα binding site at position -231/-222 from our reporter constructs reduced luciferase expression ( Figure 3A) , and siRNA-mediated knock down of C/EBPα mRNA significantly diminished endogenous hepcidin mRNA expression ( Figure 3B ), confirming and extending these earlier data. In contrast to STAT-3, however, C/EBPα does not seem to be involved in the activation of the hepcidin promoter in response to inflammatory stimuli (Figure 2A and 5B). are several reports that describe links between STAT and TGFβ/SMAD signalling [29] [30] [31] . While, such a link up to now was not described in the liver, SMAD proteins are implicated in the transcriptional control of hepcidin in HH 21,22 as well as in the response to iron overload or IL-6 22 . Thus, the investigation of this link may warrant further study.
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